← All patents

US20250090560A1

T cell receptors for immunotherapy

University of Texas System

Abstract

Provided are T cell receptors (TCR) and TCR variable regions that can selectively bind SLC 45 A 2 . The TCR may be utilized in various therapies, such as autologous cell transplantation, to treat a cancer, such as a cutaneous melanoma, uveal melanoma, a mucosal melanoma, or a metastatic melanoma.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Gregory LIZÉE
Priority date
October 12, 2017
Filing date
December 05, 2024
Publication date
March 20, 2025
Language
en
Metadata fetched
August 29, 2026 00:33